Safety of first-trimester exposure to topical tretinoin: Prospective cohort study [4]

Lancet

Volumn 350, Issue 9085, 1997, Pages 1143-1144

  Shapiro, Lori ^b   Pastuszak, Ann ^b   Curto, Giancarla ^b   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ANUS ATRESIA; AORTA VALVE STENOSIS; COHORT ANALYSIS; CONGENITAL HIP DISLOCATION; CONTROLLED STUDY; FEMALE; FETUS; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; KIDNEY DYSPLASIA; LETTER; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VALVULAR HEART DISEASE;

EID: 0030699433     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63790-7     Document Type: Article

References (5)

1. Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet 1992; 339: 687.
2. Lipson A, Collins FWW. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet 1993; 341: 22.
3. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993; 341: 1181-82.
4. DeWals P, Bloch, D, Calabro A, et al. Association between holoprosencephaly and exposure to topical retinoids: results of the EUROCAT survey. Pediat Perinat Epidemiol 1991; 5: 445-47.
5. Johnson K, Chambers C, Felix R, Dick L, Jones K. Pregnancy outcome in women prospectively ascertained with retin-A exposures: an ongoing study. Teratol Soc Abstr 1994: 375.